This whitepaper is taken from Chapter 18 of Scaling Software Agility.

Taken from Chapter 7, The Rational Edge of Scaling Software Agility.

In an earlier post, I noted that I would be using the FDA CFR 21 820.30 regulations as our example “stalking horse” to try to develop a reasonable and logical way of conforming agile development to these, and similar...
Continue reading this entry →